US pharma industry’s interest in new investments in Turkey

Posted on 26 June 2012

Boston, 20 June 2012 – Attending the 2012 Bio International Convention held in Boston, Nihat Ergun,Turkey’s Minister of Science, Industry and Technology, announced that Baxter International, the leadingUShealthcare company, is considering increasing its investments inTurkey. Baxter already has partnership with Eczacibasi inTurkey, one of oldest Turkish pharmaceutical companies. Ergun said “Baxter is planning an investment of USD 170-180 million in the first phase and is considering the production of new drugs inTurkey”.Turkeyis proving a magnet for US pharma companies with the 700 million USD acquisition of the Turkish generics drug manufacture Mustafa Nevzat by theUSbiotechnology company Amgen. Source: Invest in Turkey

Why not call us and find out how to see the properties and locations for yourself?
Telephone: +44 (0) 208 339 6036 or to email us, click here